PERNIX THERAPEUTICS HOLDINGS, INC.·4

Nov 26, 5:44 PM ET

Pearce Michael Cooper 4

4 · PERNIX THERAPEUTICS HOLDINGS, INC. · Filed Nov 26, 2012

Insider Transaction Report

Form 4
Period: 2012-11-23
Transactions
  • Sale

    Common Stock

    2012-11-26$7.18/sh25,917$186,13336,667 total
  • Exercise/Conversion

    Common Stock

    2012-11-23$4.20/sh+8,800$36,96045,467 total
  • Exercise/Conversion

    Common Stock

    2012-11-26$4.20/sh+25,917$108,85162,584 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2012-11-2625,9179,583 total
    Exercise: $4.20Exp: 2013-03-09Common Stock (25,917 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2012-11-238,80035,500 total
    Exercise: $4.20Exp: 2013-03-09Common Stock (8,800 underlying)
  • Sale

    Common Stock

    2012-11-23$7.41/sh8,800$65,23436,667 total
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/16/2012.
  • [F2]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.32 to $7.48, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The option which represents a right to purchase a total of 137,500 shares of which 93,200 were purchased prior to 11/23/2012 became fully exercisable on 3/9/2010.
  • [F4]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.45, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    issuerdirect_section16.xmlPrimary

    PRIMARY DOCUMENT